Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).
about
A human TREK-1/HEK cell line: a highly efficient screening tool for drug development in neurological diseasesSlow delayed rectifying potassium current (IKs ) - analysis of the in vitro inhibition data and predictive model development.Retroinverso analogs of spadin display increased antidepressant effectsDihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.Reducing QT liability and proarrhythmic risk in drug discovery and development.Mechanisms and management of doxorubicin cardiotoxicity.hERG1 potassium channel in cancer cells: a tool to reprogram immortality.Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats.Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.Rabbit ventricular myocardium undergoing simulated ischemia and reperfusion in a double compartment tissue bath: a model to investigate both antiarrhythmic and arrhythmogenic likelihoodRefining the human iPSC-cardiomyocyte arrhythmic risk assessment model.Remodeling of ventricular repolarization in a chronic doxorubicin cardiotoxicity rat model.I(Ks) blockade in border zone arrhythmias from guinea-pig ventricular myocardium submitted to simulated ischemia and reperfusion.Mechanism of doxorubicin cardiotoxicity evaluated by integrating multiple molecular effects into a biophysical model.Doxorubicin-induced changes of ventricular repolarization heterogeneity: results of a chronic rat study.Suppression of hERG K current and cardiac action potential prolongation by 4-hydroxynonenal via dual mechanismsDoxorubicin induces caspase-mediated proteolysis of KV7.1Fuzi and Banxia Combination, Eighteen Antagonisms in Chinese Medicine, Aggravates Adriamycin-Induced Cardiomyopathy Associated with PKA/2AR-Gs Signaling
P2860
Q28477495-68E95385-41E3-4CA2-8D43-093F96E5F909Q34159048-62600091-9E3C-42C2-92F6-8835AA526AAEQ34996777-AB2BAE99-0F3A-42E0-ACE1-414D06A52525Q35550223-23DA4AF9-BD84-4B4A-86FA-90375C1B9319Q37689199-C8D36817-7FBB-4885-BD45-9C3DDFCED5DCQ38473474-8FFEBE3E-AC23-410F-8667-60E6CFF661F6Q38959783-47F0258E-C370-4A65-82B2-DD8930ED3218Q39264529-6885F1D8-9CCE-448B-9344-02A9AB0654E0Q40640593-C29B5EDF-187A-4E8A-AFF1-47A16E87F541Q41892110-24FA36C9-7DF1-4923-82A0-A24C9BA83868Q42709339-BDF3591E-2833-4799-876E-FA793CA485C4Q43589125-F0228ABB-279A-48D9-ADC1-240614D24D5EQ46372877-26A16541-51C7-48CE-A96A-2BA944C190BAQ47327199-E5807C78-1241-4A19-BDAF-6C4B479FC234Q47726932-99AA8720-63F1-4356-BE94-EB83C522B321Q57095368-16A8D292-AB25-4821-9821-044AFA77612DQ57299788-728F7B93-CEA6-40CA-B6F3-16ED242B32DEQ58766694-FEAB71B5-3F2F-4251-83A7-9410506CBE0C
P2860
Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Dexrazoxane protects the heart ...... ngation: a key role for I(Ks).
@ast
Dexrazoxane protects the heart ...... ngation: a key role for I(Ks).
@en
type
label
Dexrazoxane protects the heart ...... ngation: a key role for I(Ks).
@ast
Dexrazoxane protects the heart ...... ngation: a key role for I(Ks).
@en
prefLabel
Dexrazoxane protects the heart ...... ngation: a key role for I(Ks).
@ast
Dexrazoxane protects the heart ...... ngation: a key role for I(Ks).
@en
P2093
P2860
P1476
Dexrazoxane protects the heart ...... ongation: a key role for I(Ks)
@en
P2093
C Pons-Himbert
J F Faivre
Joffrey Ducroq
M Le Grand
P2860
P304
P356
10.1111/J.1476-5381.2009.00371.X
P407
P577
2009-08-24T00:00:00Z